Keyphrases
Myeloproliferative Neoplasms
89%
Remnant Cholesterol
79%
Mendelian Randomization
69%
Atherosclerotic Cardiovascular Disease (ASCVD)
68%
Population-based Cohort Study
65%
General Population Studies
61%
Low-density Lipoprotein Cholesterol (LDL-C)
51%
High-density Lipoprotein Cholesterol (HDL-C)
46%
Copenhagen
44%
JAK2V617F
35%
Current Smokers
28%
Myocardial Infarction
26%
Peripheral Arterial Disease
26%
Ischemic Stroke
26%
Confidence Interval
23%
Hazard Ratio
23%
Triglyceride-rich Lipoproteins
23%
Patients with Diabetes
23%
JAK2V617F mutation
22%
Multivariable
21%
Inflammation
20%
Leukocytes
19%
Low-grade Inflammation
19%
White Blood Cell Count
19%
Meta-analysis
18%
Causal Evidence
18%
Smokers
18%
Myocardial Ischemia
17%
Sepsis
17%
Pediatric
16%
Diabetes
16%
Hypogonadism
16%
Population-based Prospective Cohort Study
16%
Total Body Irradiation
16%
Blood Cells
16%
Intermittent Sprints
16%
Sprint Interval Training
16%
Intermittent Training
16%
Metabolic Syndrome
16%
Cohort-based
16%
Exercise Rehabilitation
16%
Plasma Triglycerides
16%
Mean Corpuscular Volume
16%
Particle-associated
16%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
16%
Pneumonia Mortality
16%
Non-cardiovascular Mortality
16%
White Blood Cells
16%
Red Blood Cells
16%
Low-density Lipoprotein
16%
Medicine and Dentistry
Population
66%
Cohort Analysis
65%
Population Research
59%
Low Density Lipoprotein Cholesterol
51%
High Density Lipoprotein Cholesterol
41%
Arteriosclerosis Obliterans
41%
Myeloproliferative Neoplasm
37%
Myocardial Infarction
36%
Mendelian Randomization Analysis
35%
High-Density Lipoprotein
34%
Malignant Neoplasm
28%
Leukocyte
28%
Brain Ischemia
24%
Triglyceride-Rich Lipoprotein
22%
Infection
19%
Smoking
19%
Cell Count
19%
Low-Density Lipoprotein
18%
Cardiovascular System
18%
Sepsis
17%
Kidney Function
16%
Pediatrics
16%
Hematopoiesis
16%
Exercise Rehabilitation
16%
Metabolic Syndrome
16%
Prospective Cohort Study
16%
Whole Body Radiation
16%
Cardiovascular Mortality
16%
Hypogonadism
16%
Allogeneic Hematopoietic Stem Cell Transplantation
16%
Triacylglycerol
16%
Diabetes
16%
Erythrocyte
16%
Lymphocyte
16%
Hazard Ratio
16%
Quality of Life
13%
Interleukin 6
12%
Apolipoprotein A1
12%
Neutrophil
12%
Monocyte
10%
Platelet
9%
Randomized Controlled Trial
8%
Eosinophil
8%
UK Biobank
8%
Cardiovascular Disease
8%
Blood Cell
7%
Hematopoietic Stem Cell Transplantation
7%
Ischemia
7%
Limb
7%
Lipoprotein
7%
Biochemistry, Genetics and Molecular Biology
Population
100%
Population Research
83%
HDL-Cholesterol
67%
Cohort Study
65%
Mendelian Randomization
55%
Smoking
49%
High-Density Lipoprotein
34%
Triglyceride-Rich Lipoprotein
28%
Allele
27%
Leukocyte Count
17%
Magnetism
17%
Kidney Function
16%
Allogeneic Hematopoietic Stem Cell Transplantation
16%
Hemocyte
16%
Triacylglycerol Blood Level
16%
Apolipoprotein A1
16%
Somatic Mutation
16%
Hematopoietic Stem Cell Transplantation
16%
Hematopoiesis
16%
Cardiovascular Mortality
16%
Low-Density Lipoprotein
16%
Janus Kinase
16%
Tree
16%
Lipoprotein
16%
Homozygote
15%
Leukocyte
15%
Genetics
13%
CHRNA3
12%
Clinical Trial
10%
Statin
10%
Lymphocyte
10%
Monocyte
10%
Genotyping
10%
Prevalence
9%
Interleukin-6
8%
Eosinophil Granulocyte
8%
Interleukin-6 Receptor
8%
Cholesterol Level
8%
Neutrophil Granulocyte
6%
Neutrophil-To-Lymphocyte Ratio
5%
Nuclear Magnetic Resonance Spectroscopy
5%
Lipid Profile
5%
Patient Registry
5%
Low-Density Lipoprotein
5%
